Sign In
Buy DBVT
$13.63
-0.230 (-1.66%)
At Close: Jul 24, 2026
DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
01:30am, Monday, 27'th Feb 2023
Montrouge, France, February 27, 2023
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
09:30pm, Tuesday, 21'st Feb 2023 GlobeNewswire Inc.
Montrouge, France, February 21, 2023
DBV Technologies participera au prochain congrès de l’AAAAI 2023
09:30pm, Tuesday, 21'st Feb 2023 GlobeNewswire Inc.
Montrouge, France, le 21 février (22h30 CET) 2023
DBV Technologies invitée à participer à une prochaine Conférence Investisseur
09:30pm, Friday, 10'th Feb 2023 GlobeNewswire Inc.
Montrouge, France, 10 février (22h 30 CET) 2023
DBV Technologies to Participate in Upcoming Investor Conference
09:30pm, Friday, 10'th Feb 2023 GlobeNewswire Inc.
Montrouge, France, February 10, 2023
DBV Technologies to Participate in Upcoming Investor Conference
04:30pm, Friday, 10'th Feb 2023
Montrouge, France, February 10, 2023
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
09:30pm, Monday, 23'rd Jan 2023 GlobeNewswire Inc.
AMF Regulated InformationMontrouge, France, January 23, 2023
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
09:30pm, Monday, 23'rd Jan 2023 GlobeNewswire Inc.
Informations RéglementéesMontrouge, France, le 23 janvier (22 h 30 CET) 2023
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022
09:30pm, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2022
09:30pm, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
DBV (DBVT) Up as FDA Lifts Partial Hold on Peanut Allergy Study
02:22pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
The FDA lifts the partial clinical hold on DBV Technologies' (DVBT) phase III VITESSE study of a modified Viaskin Peanut patch in peanut-allergic children aged four to seven years. Stock rises.
Dow Rises 150 Points; Mission Produce Shares Slide
07:35pm, Friday, 23'rd Dec 2022 Benzinga
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
The Dow traded up 0.45% to 33,176.46 while the NASDAQ fell 0.02% to 10,473.83. The S
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
06:24pm, Friday, 23'rd Dec 2022 Benzinga
Gainers
Expion360 Inc. (NASDAQ: XPON) shares jumped 175% to $2.70 after the company announced it has been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trail
Dow Surges Over 100 Points; Crude Oil Rises Sharply
05:15pm, Friday, 23'rd Dec 2022 Benzinga
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
The Dow traded up 0.36% to 33,145.35 while the NASDAQ fell 0.13% to 10,462.81. The S&P 50
Why DBV Technologies Stock Is Soaring Today
05:01pm, Friday, 23'rd Dec 2022 The Motley Fool
The company can now move forward with a late-stage study of its lead pipeline candidate.
